{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-000728","form_type":"8-K","ticker":"CFOR","cik":"0001293818","company_name":"CapForce Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.299174+00:00","generated_at":"2026-06-15T00:45:34.545267+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OpGen Q1 revenue $0.91M (up 94% YoY), FDA UTI submission, Fisher deal, cash burn guidance","bullets":["Q1 2023 revenue $0.91M, up 94% YoY ($0.47M) and 26% QoQ ($0.72M).","Submitted De Novo FDA application for Unyvero UTI panel; FDA confirmed complete review initiated.","Non-exclusive distribution agreement with Fisher Healthcare for Unyvero A50 platform and tests.","Cash $7.0M at Mar 31; 2023 guidance: revenue $4-5M, net cash consumption $4.5-5M/quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-000728","json":"https://secwatch.observer/filing/0001079973-23-000728.json","markdown":"https://secwatch.observer/filing/0001079973-23-000728.md","text":"https://secwatch.observer/filing/0001079973-23-000728.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323000728/0001079973-23-000728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323000728/opgen_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:45:34.545267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"722b64293fe0211df747644156a24a4f0b8d6ba9","claim":"CapForce Inc. reported first quarter 2023 results: revenue $0.91 million. Guidance reaffirmed.","evidence_excerpt":"Total revenue for the first quarter of 2023 was approximately $0.91 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323000728/0001079973-23-000728-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2023"},{"label":"Revenue","value":"$0.91 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}